Carbon-Ion Radiotherapy for Cancer Treatment
A special issue of Cancers (ISSN 2072-6694).
Deadline for manuscript submissions: closed (30 June 2021) | Viewed by 4422
Special Issue Editor
Special Issue Information
Dear Colleagues,
Carbon-ion radiotherapy (CIRT) has excellent dose-intensity and strong biological effects compared to conventional radiotherapy, and by taking advantage of these characteristics, CIRT can provide less invasive and more locally effective treatment compared to conventional radiotherapy. The clinical application of CIRT was first attempted in the United States, but many clinical results have been achieved in Japan since 1994. Although the number of CIRT facilities has been increasing in recent years, there are still only about a dozen CIRT facilities in the world, and the number of CIRT facilities is still far from the rapid growth of proton beam therapy facilities.
In order to promote the spread of CIRT in the future and to provide many patients with the benefits of CIRT with its excellent clinical efficacy, it is essential to provide a large amount of evidence. In addition, as treatment is becoming more precise, both physically and biologically, the amount of labor required is increasing, and efficiency and labor saving are important factors for the widespread use of treatment.
In this Special Issue, we welcome submissions from the following categories:
- Clinical data on CIRT at single and multiple facilities;
- Inventions in the calculation of treatment techniques and treatment plans for highly accurate CIRT;
- A biological study of the differences in the effects of CIRT on normal tissues and tumor cell types;
- The cost-effectiveness of CIRT
Dr. Hiroyuki Katoh
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- carbon-ion radiotherapy
- treatment planning
- quality control and quality assurance
- patients’ outcome
- normal tissue reaction
- radiobiology
